【レポートの概要（一部）】
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Market Snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Increasing number of market players
3.1.1.2 Increasing application of doxorubicin
3.1.1.3 Growing number of cancer cases
3.1.2 Market restraint analysis
3.1.2.1 Supply demand gap
3.2 Penetration & Growth Prospect Mapping
3.3 Doxorubicin Market- SWOT Analysis, by Factor (Political &Legal, Economic, and Technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Market Categorization 1: Application Estimates & Trend Analysis
4.1 Doxorubicin Market: ApplicationMovement Analysis
4.2 Ovarian Cancer
4.2.1 Ovarian cancer market estimates and forecasts, 2013 – 2024 (USD Million)
4.3 Multiple Myeloma
4.3.1 Multiple myeloma market estimates and forecasts, 2013 – 2024 (USD Million)
4.4 Kaposi Sarcoma
4.4.1 Kaposi Sarcoma market estimates and forecasts, 2013 – 2024 (USD Million)
4.5 Leukemia
4.5.1 Leukemia market estimates and forecasts, 2013 – 2024 (USD Million)
4.6 Bone sarcoma
4.6.1 Bone sarcoma market estimates and forecasts, 2013 – 2024 (USD Million)
4.7 Breast cancer
4.7.1 Breast cancer market estimates and forecasts, 2013 – 2024 (USD Million)
4.8 Endometrial cancer
4.8.1 Endometrial cancer market estimates and forecasts, 2013 – 2024 (USD Million)
4.9 Gastric cancer
4.9.1 Gastric cancer market estimates and forecasts, 2013 – 2024 (USD Million)
4.10 Liver cancer
4.10.1 Liver cancer market estimates and forecasts, 2013 – 2024 (USD Million)
4.11 Kidney cancer
4.11.1 Kidney cancer market estimates and forecasts, 2013 – 2024 (USD Million)
4.12 Other cancer
4.12.1 Other cancer market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 5 Market Categorization 4: Regional Estimates & Trend Analysis
5.1 Doxorubicin Market Share by Region, 2013 & 2024
5.2 North America
5.2.1 North America doxorubicin market estimates and forecasts, by application 2013 – 2024(USD Million)
5.2.2 U.S.
5.2.2.1 U.S. doxorubicin market estimates and forecasts, by application 2013 – 2024 (USD Million)
5.2.3 Canada
5.2.3.1 Canada doxorubicin market estimates and forecasts, by application 2013 – 2024 (USD Million)
5.3 Europe
5.3.1 Europe doxorubicin market estimates and forecasts, by application 2013 – 2024 (USD Million)
5.3.2 Germany
5.3.2.1 Germany doxorubicin market estimates and forecasts, by application 2013 – 2024 (USD Million)
5.3.3 UK
5.3.3.1 UK doxorubicin market estimates and forecasts, by application 2013 – 2024 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific doxorubicin market estimates and forecasts, by application 2013 – 2024 (USD Million)
5.4.2 Japan
5.4.2.1 Japan doxorubicin market estimates and forecasts, by application 2013 – 2024 (USD Million)
5.4.3 China
5.4.3.1 China doxorubicin market estimates and forecasts, by application 2013 – 2024 (USD Million)
5.5 Latin America
5.5.1 Latin America doxorubicin market estimates and forecasts, by application 2013 – 2024 (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil doxorubicin market estimates and forecasts, by application 2013 – 2024 (USD Million)
5.5.3 Mexico
5.5.3.1 Mexico doxorubicin market estimates and forecasts, by application 2013 – 2024 (USD Million)
5.6 MEA
5.6.1 MEA doxorubicin market estimates and forecasts, by application 2013 – 2024 (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa doxorubicin market estimates and forecasts, by application 2013 – 2024 (USD Million)
Chapter 6 Competitive Landscape
6.1 Strategy Framework
6.2 Market Participation Categorization
6.3 Company Profiles
6.3.1 Pfizer, Inc.
6.3.1.1 Company overview
6.3.1.2 Financial performance
6.3.1.3 Product benchmarking
6.3.1.4 Strategic initiatives
6.3.2 Sun Pharmaceutical Industries Ltd.
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 Product benchmarking
6.3.2.4 Strategic initiatives
6.3.3 Cipla, Inc.
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 Product benchmarking
6.3.3.4 Strategic initiatives
6.3.4 Cadila Pharmaceuticals
6.3.4.1 Company overview
6.3.4.2 Financial performance
6.3.4.3 Product benchmarking
6.3.4.4 Strategic initiatives
6.3.5 SRS PHARMACEUTICALS PVT. LTD.
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.5.4 Strategic initiatives
6.3.6 Janssen Products, LP
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 Product benchmarking
6.3.6.4 Strategic initiatives
【レポート販売概要】
■ タイトル：ドキソルビシンの世界市場分析：用途別（卵巣がん、多発性骨髄腫、カポジ肉腫、白血病、骨肉腫、乳房、子宮内膜がん、胃がん、肝臓がん、腎臓がん、他のがん）、セグメント予測、2013 – 2024■ 英文：Doxorubicin Market By Application (Ovarian, Multiple Myeloma, Kaposi Sarcoma, Leukemia, Bone Sarcoma, Breast, Endometrial, Gastric, Liver, Kidney, Other Cancers) And Segment Forecasts, 2013 - 2024
■ 発行日：2016年11月23日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707263
■ 調査対象地域：グローバル
- テラヘルツ技術の世界市場：テラヘルツ画像、テラヘルツ分光法、テラヘルツ通信システムThe terahertz technology market is expected to grow at CAGR of 31.83% between 2016 and 2022 to reach USD 489.8 Million by 2022. The key drivers responsible for the growth of this market include the increase in demand for terahertz technology-based products in the defense & homeland security and medical sectors and the high adoption rate of these products for laboratory research applications. The i …
- 病院照明の世界市場予測（～2021年）：トロッファー、表面実装型ライト、手術用ランプThe hospital lighting market is projected to reach USD 7.03 Billion by 2021 from USD 5.19 Billion in 2016, at a CAGR of 6.2% from 2016 to 2021. The increasing adoption of LED based lighting products and increasing number of hospital in emerging economies are the key factor driving the market growth. Moreover, increasing government support to energy efficiency program for hospitals is contributing …
- Erbitux：大腸癌治療薬市場分析Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023”. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus represents a huge burden on h …
- チューインガムの世界市場2016-2020：無糖（シュガーレス）チューインガム、有糖チューインガムAbout Chewing Gum Chewing gum is a product that is mostly bought on impulse. Therefore, attractive packaging and the correct placement of these products, like at the checkout zones of supermarkets and hypermarkets, are expected to drive the market during the forecast period. Chewing, especially for an extended period, is regarded as indecorous in many countries such as Japan, Thailand, Malaysia, a …
- 2,5-Bis[(1,3-ジオキソブチル)アミノ]ベンゼンスルホン酸の世界市場2,5-Bis[(1,3-dioxobutyl)amino]benzenesulfonic Acid (CAS 70185-87-4) Market Research Report 2013 presents comprehensive data on 2,5-bis[(1,3-dioxobutyl)amino]benzenesulfonic acid markets globally and regionally (Europe, Asia, North America etc.) The 2,5-Bis[(1,3-dioxobutyl)amino]benzenesulfonic Acid (CAS 70185-87-4) Market Research Report 2013 includes 2,5-bis[(1,3-dioxobutyl)amino]benzenesulfonic …
- ガスセンサの世界市場：電気化学式、赤外線、MOS（金属酸化膜半導体）、触媒式、ジルコニア、レーザー、光イオン化検出The gas sensors market is expected to be worth USD 1.01 Billion by 2022, growing at a CAGR of 6.22% between 2016 and 2022. The major drivers for the growth are increasing government’s safety regulations at the workplace in industries and growing demand for wireless gas sensors. Of all the major applications, the oil & gas and medical applications hold the major share of the gas sensors market. The …
- 頸動脈洞性失神：グローバル臨床試験レビュー（2014年上半期）Carotid Sinus Syncope Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Carotid Sinus Syncope Global Clinical Trials Review, H1, 2014" provides data on the Carotid Sinus Syncope clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Carotid Sinus Syncope. It includes an overview of the trial numbers and the …
- 内視鏡：現在および将来プレイヤーEndoscopy - Current and Future Players Summary The Endoscopy market in Europe is a dynamic market that is expected to grow through 2021. The market is also very saturated with intense competition due to the availability of similar product offerings across market players. In the face of increasing hospital consolidation into one network and the trend of oligopoly purchasing, i.e. purchasing more pr …
- FRP（繊維強化プラスチック）製橋の世界市場予測（～2021）The report concentrates on the utilization of various FRP materials used in the manufacturing of bridges. The FRP bridge market is projected to reach USD 72.5 Million by 2021, at a CAGR of 6.40% from 2016 to 2021. The increasing demand for FRP materials to enhance the strength and stiffness of structural parts of FRP bridges, such as decks, girders, and rebars, is driving the growth of the FRP bri …
- アダプティブ・ライセンス：薬剤開発及び規制のための包括的アプローチAdaptive Licensing (AL) is a flexible approach to drug development and regulation, with two live pilot schemes accepted by the European Medicines Agency (EMA). The system acknowledges that levels of uncertainty will always surround innovative treatments. An initial license is granted at an earlier stage than possible under the traditional system, with less clinical information from Randomized Cont …
- クラウド式PLMの世界市場予測（～2021年）The Cloud Based PLM Market is expected to grow from USD 18.65 Billion in 2016 to USD 40.55 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 16.80% during the forecast period. Rising need for integrated PLM solution, effective management of supply chain, and increasing adoption of Internet of Things (IoT) are driving the cloud PLM market. The customer management is expected to grow at th …
- 世界の高級ホテル市場Summary The global luxury hotels market's performance has recovered from the slowdown recorded at the beginning of the historic period (2009-2013) due to the financial crisis and recession. Overall, growth was recorded in the four markets - Americas, Asia-Pacific, Europe, Middle East and Africa - across all key performance indicators (KPIs) during the historic period. Growth is expected to continu …
- がん医療におけるゲノミクスの世界市場分析：製品別（機器、消耗品、サービス）、用途別（診断、個別化医療、薬の発見･開発、研究）、技術別（ゲノム配列決定、PCR、マイクロアレイ、核酸抽出および精製）、エンドユーザー別（病院、研究機関、学術機関）、セグメント予測Global genomics in cancer care market is expected to reach USD 9.22 billion by 2022, according to a new report by Grand View Research, Inc. Increasing prevalence of cancer coupled with adoption of next generation sequencing for the diagnosis & treatment is expected to fuel the market with future growth opportunities. Increasing incidences of cancer triggers the demand for cost effective and accura …
- 界面活性剤の世界市場分析：製品別（カチオン性、非イオン性、アニオン性、両性）、用途別（ホームケア、パーソナルケア、産業および施設洗浄剤、食品加工、油田化学、農薬、繊維、乳化重合、塗料および塗装、建設）、セグメント予測、– 2022The global surfactants market is expected to reach USD 46.20 billion by 2022, according to a new report by Grand View Research, Inc. Growth of personal care industry particularly in Asia Pacific, Latin America and Middle East is expected to remain a key driving factor for the global market. Growing demand for oilfield chemicals owing increasing drilling activities for unconventional energy in the …
- 車載用インフォテインメントのグローバル市場（2014-2018）About Automotive Infotainment Automotive infotainment is the blend of entertainment and information systems in automobiles. An infotainment system includes in-vehicle navigation, audio, video and internet. It also includes embedded and mobile navigation systems, telematics systems and video systems that are used by passengers or when the car is parked. The key benefits of infotainment systems such …
